Forbes magazine interviewed oncologist David Agus, whose patients included Apple co-founder. The doctor, among other things, told how medicine saved Steve Jobs from the disease and why in the end could not do it. On the other hand, his life was extended for several years.
Among the negative factors, David Agus called the lack of prevention. Steve Jobs has never been involved in cancer prevention or even drank aspirin, which “reduces the risk of developing cancer by 30%, the risk of cancer of the lungs, colon and prostate – by 46%.” In addition, the head of Apple for too long refused an operation that could probably save his life.
“And yet, due to advanced treatment methods, we extended his life for six full years, this is a lot. He did not die shortly after the diagnosis was announced, he did not painfully die these six years, but lived. Before his death, he managed to say goodbye to his friends and relatives, ” added David Agus.
The oncologist told in more detail how they saved Steve Jobs. This, of course, is about the latest techniques at that time.
“We sequenced the genes of his tumors to select specific drugs that will fight cell defects that turn them into cancer. It was a revolutionary approach, completely different from conventional therapy, which most often hits the cells of the whole body, both healthy and cancerous, preventing them from sharing.
We, the medical team, seemed to play chess. They made a move using a certain “cocktail” of medicines, many of which were experimental and had not yet gone into production, and then waited for the cancer to respond. When he mutated and found another tricky way to circumvent the effect of the drugs used, we made a new move – we found a different combination of drugs, ”added David Agus.
Theoretically, Steve Jobs’s cancer could be turned into a molecular-controlled chronic disease. Unfortunately, at that time the process of sequencing itself and interpreting the finished genetic profile was far from ideal and was largely subjective in nature, allowing for ambiguous interpretations by different medical teams.
This happened with the co-founder of Apple. Two universities received slightly different DNA tests from his tumor. Doctors had to develop an increasingly complex strategy that would take into account the results of the work of both teams.